EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Time-trend analysis of 78 orbicularis oculi myocutaneous flaps in periorbital reconstruction: a single-center retrospective study in South Korea

Yong Chan Bae, Yong Woo Lee, Chi Hyun Lee, Hoon-Soo Kim

Archives of Craniofacial Surgery · 2025-10-20 · 26 (5) · 190-196

DOI: 10.7181/acfs.2025.0028 ↗
AbstractBibliografische Angaben

Abstract

Background: The orbicularis oculi myocutaneous (OOMC) flap offers an excellent match in color, thickness, and texture for periorbital defects, yet large-scale, long-term data remain scarce. To determine whether indications, flap‑design preferences, and complication profiles change as surgical experience accumulates, cases were stratified into an early practice phase (2001–2017) and a contemporary phase following technique refinement and wider adoption (2018–2024).Methods: All periorbital reconstructions utilizing OOMC flaps between November 2001 and December 2024 were retrospectively reviewed. Cases were stratified into Group A (2001–2017) and Group B (2018–2024). We analyzed patient age, sex, etiology, defect site/number, flap design (V-Y advancement, unipedicle/bipedicle switch, pivot), adjunctive procedures, and complications.Results: Seventy-eight OOMC flaps were performed in 57 patients for 70 defects. Group A included 25 patients, 30 defects, and 36 flaps, while Group B included 32 patients, 40 defects, and 42 flaps. Basal cell carcinoma was the leading etiology in both periods (77%). The proportion of V-Y advancement flaps rose from 50% (18/36) in Group A to 83% (35/42) in Group B. No flap necrosis occurred, and tumor recurrence was observed only once in Group A.Conclusion: Despite the relatively short observation window for Group B, OOMC flap use increased markedly, confirming that accumulated surgical experience promotes even more frequent application in periorbital reconstruction. The V-Y advancement variant, in particular, expanded in indication without added morbidity and appears highly reliable for a broad spectrum of periorbital defects.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →